After this educational work, in the investigative part, we have shown that testing retrospectively as well as prospectively for glucocerebrosidase and acid sphingomyelinase activity using DBS testing should become a routine practice to characterize splenomegaly of unknown etiology. This evidence concerns the gene SMPD1 and Splenomegaly.